Novel insights into the role of aptamers in the fight against cancer Yasen MaimaitiyimingDe Fei HongHua Naranmandura Review – Cancer Research 04 March 2019 Pages: 797 - 810
A three-gene methylation marker panel for the nodal metastatic risk assessment of muscle-invasive bladder cancer Beatrice StubendorffKerstin WilhelmKerstin Junker Original Article – Cancer Research 02 January 2019 Pages: 811 - 820
Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status Claudia OmariniStefania BettelliFederico Piacentini Original Article – Cancer Research 02 January 2019 Pages: 821 - 828
Computer-assisted medical image classification for early diagnosis of oral cancer employing deep learning algorithm Pandia Rajan JeyarajEdward Rajan Samuel Nadar Original Article – Cancer Research 03 January 2019 Pages: 829 - 837
High frequency of H3 K27M mutations in adult midline gliomas Azadeh EbrahimiMarco SkardellyJens Schittenhelm Original Article – Cancer Research 04 January 2019 Pages: 839 - 850
Pathobiological role of cleft palate transmembrane protein 1 family proteins in oral squamous cell carcinoma Keisuke InoueKiichi HatanoTamotsu Takeuchi Original Article – Cancer Research 11 January 2019 Pages: 851 - 859
GLRX inhibition enhances the effects of geftinib in EGFR-TKI-resistant NSCLC cells through FoxM1 signaling pathway Linlin WangJing LiuYuanlin Song Original Article – Cancer Research 19 January 2019 Pages: 861 - 872
Prevalence and clinical significance of RBM3 immunostaining in non-small cell lung cancers Nathaniel MellingKai BachmannKatharina Grupp Original Article – Cancer Research 13 February 2019 Pages: 873 - 879
NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance Francesco MaramponSilvia CodenottiPaolo Tini Original Article – Cancer Research 30 January 2019 Pages: 881 - 893
Insufficient radiofrequency ablation promotes the metastasis of residual hepatocellular carcinoma cells via upregulating flotillin proteins Ning ZhangHui LiLu Wang Original Article – Cancer Research Open access 28 February 2019 Pages: 895 - 907
Expression of Syk and MAP4 proteins in ovarian cancer Siwei ZhangSuha DeenStewart G. Martin Original Article – Cancer Research Open access 08 February 2019 Pages: 909 - 919
Adherence to the EAU guidelines on Penile Cancer Treatment: European, multicentre, retrospective study Maida BadaFrancesco BerardinelliLuigi Schips Original Article – Cancer Research 01 March 2019 Pages: 921 - 926
Mistletoe in oncological treatment: a systematic review M. FreudingC. KeinkiJutta Huebner Review – Clinical Oncology 23 January 2019 Pages: 927 - 939
T cell-redirecting bispecific antibodies in cancer immunotherapy: recent advances Lin YuJianhua Wang Review – Clinical Oncology 23 February 2019 Pages: 941 - 956
Preoperative controlling nutritional status (CONUT) score as a novel immune-nutritional predictor of survival in non-metastatic clear cell renal cell carcinoma of ≤ 7 cm on preoperative imaging Ahmed ElghiatyJongchan KimWon Sik Ham Original Article – Clinical Oncology 13 February 2019 Pages: 957 - 965
Prognostic role of glycolysis for cancer outcome: evidence from 86 studies Min YuShengying ChenZhixiang Jian Original Article – Clinical Oncology 01 March 2019 Pages: 967 - 999
Reduced vs. standard dose native E. coli-asparaginase therapy in childhood acute lymphoblastic leukemia: long-term results of the randomized trial Moscow–Berlin 2002 Alexander KarachunskiyGesche Tallenfor the ALL-MB study group Original Article – Clinical Oncology Open access 06 March 2019 Pages: 1001 - 1012
Cancer risk in stroke survivors followed for up to 10 years in general practices in Germany Louis JacobKarel Kostev Original Article – Clinical Oncology 09 February 2019 Pages: 1013 - 1020
Does FDG PET/CT have a role in determining adjuvant chemotherapy in surgical margin-negative stage IA non-small cell lung cancer patients? Hye Lim ParkIe Ryung YooSeok Whan Moon Original Article – Clinical Oncology 13 February 2019 Pages: 1021 - 1026
Aggregate analysis based on TCGA: TTN missense mutation correlates with favorable prognosis in lung squamous cell carcinoma Xingyu ChengHan YinHong Shen Original Article – Clinical Oncology 27 February 2019 Pages: 1027 - 1035
Regorafenib in patients with recurrent high-grade astrocytoma Sied KebirLaurel RauschenbachMartin Glas Original Article – Clinical Oncology 28 February 2019 Pages: 1037 - 1042
Prognostic relevance of programmed cell death-ligand 1 expression and CD8+ TILs in rectal cancer patients before and after neoadjuvant chemoradiotherapy Tsung-Wei ChenKevin Chih-Yang HuangK. S. Clifford Chao Original Article – Clinical Oncology 14 March 2019 Pages: 1043 - 1053
Lymph node ratio predictive of recurrence, distant metastasis, and survival in submandibular gland carcinoma patients Won Ki ChoJong-Lyel RohSang Yoon Kim Original Article – Clinical Oncology 26 February 2019 Pages: 1055 - 1062
Vascular endothelial growth factor receptor 2 (VEGFR2) correlates with long-term survival in patients with advanced high-grade serous ovarian cancer (HGSOC): a study from the Tumor Bank Ovarian Cancer (TOC) Consortium Jun GuanSilvia Darb-EsfahaniElena Ioana Braicu Original Article – Clinical Oncology 27 February 2019 Pages: 1063 - 1073
Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guidance for rectal cancer patients: efficacy and safety in a large, multi-institutional series Berardino De BariAlessandra Franzetti-PellandaMahmut Ozsahin Original Article – Clinical Oncology Open access 04 March 2019 Pages: 1075 - 1084
Retraction Note to: SOX2 oncogenes amplified and operate to activate AKT signalling in gastric cancer and predict immunotherapy responsiveness Yajun TianXin JiaMaosheng Dong Retraction Note 11 March 2019 Pages: 1085 - 1085
